Ostarine
Half-Life (t½) PO: 24h
Formula C19H14F3N3O3
Molecular Weight 389.33 g/mol
Aliases MK-2866, GTx-024, Enobosarm Pharmacological Mechanism First-generation non-steroidal SARM. Gentle AR activation producing muscle anabolism + bone density with minimal prostate / virilising effects. The most-studied SARM in human trials (POWER trials in NSCLC + breast cancer cachexia).
Half-Life & Elimination Curve (PO: 24h) 100% 50% 25% 12.5% 0% 0h 0×t½ 24h 1×t½ 48h 2×t½ 3d 3×t½ 4d 4×t½ 5d 5×t½ 0×t½ (0h): 100% remaining 1×t½ (24h): 50% remaining 2×t½ (48h): 25% remaining 3×t½ (3d): 12.5% remaining 4×t½ (4d): 6.3% remaining 5×t½ (5d): 3.1% remaining Elimination (PO)
0×t½ 0h 100% 1×t½ 24h 50% 2×t½ 48h 25% 3×t½ 3d 12.5% 4×t½ 4d 6.3% 5×t½ 5d 3.1% Dosing Guidelines Oral (PO): Typical 16.7 mg (Range: 10–30 mg)Pathways It Modulates Target Organ Systems Endocrine System Reproductive System Musculoskeletal System Chemical Structure & Identifiers InChIKey: JNGVJMBLXIUVRD-SFHVURJKSA-NSMILES: C[C@](COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)OReferences Directory Compounds Registry Human Biology Hub